Cargando…

Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts

Even distinct cancer types share biological hallmarks. Here, we investigate polygenic risk score (PRS)-specific pleiotropy across 16 cancers in European ancestry individuals from the Genetic Epidemiology Research on Adult Health and Aging cohort (16,012 cases, 50,552 controls) and UK Biobank (48,969...

Descripción completa

Detalles Bibliográficos
Autores principales: Graff, Rebecca E., Cavazos, Taylor B., Thai, Khanh K., Kachuri, Linda, Rashkin, Sara R., Hoffman, Joshua D., Alexeeff, Stacey E., Blatchins, Maruta, Meyers, Travis J., Leong, Lancelote, Tai, Caroline G., Emami, Nima C., Corley, Douglas A., Kushi, Lawrence H., Ziv, Elad, Van Den Eeden, Stephen K., Jorgenson, Eric, Hoffmann, Thomas J., Habel, Laurel A., Witte, John S., Sakoda, Lori C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880989/
https://www.ncbi.nlm.nih.gov/pubmed/33579919
http://dx.doi.org/10.1038/s41467-021-21288-z
_version_ 1783650784370491392
author Graff, Rebecca E.
Cavazos, Taylor B.
Thai, Khanh K.
Kachuri, Linda
Rashkin, Sara R.
Hoffman, Joshua D.
Alexeeff, Stacey E.
Blatchins, Maruta
Meyers, Travis J.
Leong, Lancelote
Tai, Caroline G.
Emami, Nima C.
Corley, Douglas A.
Kushi, Lawrence H.
Ziv, Elad
Van Den Eeden, Stephen K.
Jorgenson, Eric
Hoffmann, Thomas J.
Habel, Laurel A.
Witte, John S.
Sakoda, Lori C.
author_facet Graff, Rebecca E.
Cavazos, Taylor B.
Thai, Khanh K.
Kachuri, Linda
Rashkin, Sara R.
Hoffman, Joshua D.
Alexeeff, Stacey E.
Blatchins, Maruta
Meyers, Travis J.
Leong, Lancelote
Tai, Caroline G.
Emami, Nima C.
Corley, Douglas A.
Kushi, Lawrence H.
Ziv, Elad
Van Den Eeden, Stephen K.
Jorgenson, Eric
Hoffmann, Thomas J.
Habel, Laurel A.
Witte, John S.
Sakoda, Lori C.
author_sort Graff, Rebecca E.
collection PubMed
description Even distinct cancer types share biological hallmarks. Here, we investigate polygenic risk score (PRS)-specific pleiotropy across 16 cancers in European ancestry individuals from the Genetic Epidemiology Research on Adult Health and Aging cohort (16,012 cases, 50,552 controls) and UK Biobank (48,969 cases, 359,802 controls). Within cohorts, each PRS is evaluated in multivariable logistic regression models against all other cancer types. Results are then meta-analyzed across cohorts. Ten positive and one inverse cross-cancer associations are found after multiple testing correction. Two pairs show bidirectional associations; the melanoma PRS is positively associated with oral cavity/pharyngeal cancer and vice versa, whereas the lung cancer PRS is positively associated with oral cavity/pharyngeal cancer, and the oral cavity/pharyngeal cancer PRS is inversely associated with lung cancer. Overall, we validate known, and uncover previously unreported, patterns of pleiotropy that have the potential to inform investigations of risk prediction, shared etiology, and precision cancer prevention strategies.
format Online
Article
Text
id pubmed-7880989
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78809892021-02-24 Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts Graff, Rebecca E. Cavazos, Taylor B. Thai, Khanh K. Kachuri, Linda Rashkin, Sara R. Hoffman, Joshua D. Alexeeff, Stacey E. Blatchins, Maruta Meyers, Travis J. Leong, Lancelote Tai, Caroline G. Emami, Nima C. Corley, Douglas A. Kushi, Lawrence H. Ziv, Elad Van Den Eeden, Stephen K. Jorgenson, Eric Hoffmann, Thomas J. Habel, Laurel A. Witte, John S. Sakoda, Lori C. Nat Commun Article Even distinct cancer types share biological hallmarks. Here, we investigate polygenic risk score (PRS)-specific pleiotropy across 16 cancers in European ancestry individuals from the Genetic Epidemiology Research on Adult Health and Aging cohort (16,012 cases, 50,552 controls) and UK Biobank (48,969 cases, 359,802 controls). Within cohorts, each PRS is evaluated in multivariable logistic regression models against all other cancer types. Results are then meta-analyzed across cohorts. Ten positive and one inverse cross-cancer associations are found after multiple testing correction. Two pairs show bidirectional associations; the melanoma PRS is positively associated with oral cavity/pharyngeal cancer and vice versa, whereas the lung cancer PRS is positively associated with oral cavity/pharyngeal cancer, and the oral cavity/pharyngeal cancer PRS is inversely associated with lung cancer. Overall, we validate known, and uncover previously unreported, patterns of pleiotropy that have the potential to inform investigations of risk prediction, shared etiology, and precision cancer prevention strategies. Nature Publishing Group UK 2021-02-12 /pmc/articles/PMC7880989/ /pubmed/33579919 http://dx.doi.org/10.1038/s41467-021-21288-z Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Graff, Rebecca E.
Cavazos, Taylor B.
Thai, Khanh K.
Kachuri, Linda
Rashkin, Sara R.
Hoffman, Joshua D.
Alexeeff, Stacey E.
Blatchins, Maruta
Meyers, Travis J.
Leong, Lancelote
Tai, Caroline G.
Emami, Nima C.
Corley, Douglas A.
Kushi, Lawrence H.
Ziv, Elad
Van Den Eeden, Stephen K.
Jorgenson, Eric
Hoffmann, Thomas J.
Habel, Laurel A.
Witte, John S.
Sakoda, Lori C.
Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts
title Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts
title_full Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts
title_fullStr Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts
title_full_unstemmed Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts
title_short Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts
title_sort cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880989/
https://www.ncbi.nlm.nih.gov/pubmed/33579919
http://dx.doi.org/10.1038/s41467-021-21288-z
work_keys_str_mv AT graffrebeccae crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT cavazostaylorb crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT thaikhanhk crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT kachurilinda crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT rashkinsarar crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT hoffmanjoshuad crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT alexeeffstaceye crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT blatchinsmaruta crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT meyerstravisj crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT leonglancelote crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT taicarolineg crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT emaminimac crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT corleydouglasa crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT kushilawrenceh crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT zivelad crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT vandeneedenstephenk crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT jorgensoneric crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT hoffmannthomasj crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT habellaurela crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT wittejohns crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts
AT sakodaloric crosscancerevaluationofpolygenicriskscoresfor16cancertypesintwolargecohorts